BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38307189)

  • 1. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
    Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
    Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
    Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
    Front Genet; 2022; 13():833928. PubMed ID: 35330731
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Cancer-Testis Antigen-Related Signature to Predict the Prognosis in Stomach Adenocarcinoma.
    Bian G; Cao J; Li W; Huang D; Ding X; Zang X; Ye Y; Li P
    J Cancer; 2024; 15(11):3596-3611. PubMed ID: 38817874
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 13. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
    Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
    J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 17. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma.
    Liu R; Huang B; Shao Y; Cai Y; Liu X; Ren Z
    J Transl Med; 2023 Sep; 21(1):648. PubMed ID: 37735667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.
    Wang N; Liu D
    Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.